Karsten Spiekermann

The target landscape of clinical kinase drugs

Susan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm et al. · Science · 2017 · 845 citations · Full text

Tumor Biology, Proteomicsdb Database, Drug Target +14

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

Klaus H. Metzeler, Tobias Herold, Maja Rothenberg‐Thurley et al. · Blood · 2016 · 523 citations · Full text

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

Klaus H. Metzeler, Manuela Hummel, Clara D. Bloomfield et al. · Blood · 2008 · 445 citations · Full text

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)

Benjamin Hanfstein, Marc Müller, Rüdiger Hehlmann et al. · Leukemia · 2012 · 416 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Health Sciences +10

KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

Susanne Schnittger, Tobias Kohl, Torsten Haferlach et al. · Blood · 2005 · 378 citations · Full text